Also Known As
CBC
Hemogram
CBC with Differential
Formal Name
Complete Blood Count
This article was last reviewed on
This article waslast modified on July 11, 2018.
At a Glance
Why Get Tested?

To determine your general health status; to screen for, diagnose, or monitor any one of a variety of diseases and conditions that affect blood cells, such as anemia, infection, inflammation, bleeding disorder or cancer

When To Get Tested?

As part of a routine medical exam; when you have signs and symptoms that may be related to a condition that affects blood cells; at regular intervals to monitor treatment or when you are receiving treatment known to affect blood cells

Sample Required?

A blood sample drawn from a vein in your arm or a fingerstick or heelstick (newborns)

Test Preparation Needed?

None

What is being tested?

The complete blood count (CBC) is a test that evaluates the cells that circulate in blood. Blood consists of three types of cells suspended in fluid called plasma: white blood cells (WBCs), red blood cells (RBCs), and platelets (PLTs). They are produced and mature primarily in the bone marrow and, under normal circumstances, are released into the bloodstream as needed.

A CBC is typically performed using an automated instrument that measures various parameters, including counts of the cells that are present in a person's sample of blood. The results of a CBC can provide information about not only the number of cell types but also can give an indication of the physical characteristics of some of the cells. A standard CBC includes the following:

  • Evaluation of white blood cells: WBC count; may or may not include a WBC differential
  • Evaluation of red blood cells: RBC count, hemoglobin (Hb), hematocrit (Hct) and RBC indices, which includes mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), and red cell distribution width (RDW). The RBC evaluation may or may not include reticulocyte count.
  • Evaluation of platelets: platelet count; may or may not include mean platelet volume (MPV) and/or platelet distribution width (PDW)

Significant abnormalities in one or more of the blood cell populations can indicate the presence of one or more conditions. Typically other tests are performed to help determine the cause of abnormal results. Often, this requires visual confirmation by examining a blood smear under a microscope. A trained laboratorian can evaluate the appearance and physical characteristics of the blood cells, such as size, shape and color, noting any abnormalities that may be present. Any additional information is noted and reported to the healthcare provider. This information gives the health practitioner additional clues as to the cause of abnormal CBC results.

The three types of cells evaluated by the CBC include:

White Blood Cells
There are five different types of WBCs, also called leukocytes, that the body uses to maintain a healthy state and to fight infections or other causes of injury. They are neutrophils, lymphocytes, basophils, eosinophils, and monocytes. They are present in the blood at relatively stable numbers. These numbers may temporarily shift higher or lower depending on what is going on in the body. For instance, an infection can stimulate the body to produce a higher number of neutrophils to fight off bacterial infection. With allergies, there may be an increased number of eosinophils. An increased number of lymphocytes may be produced with a viral infection. In certain disease states, such as leukemia, abnormal (immature or mature) white cells rapidly multiply, increasing the WBC count.

Red Blood Cells
Red blood cells, also called erythrocytes, are produced in the bone marrow and released into the bloodstream as they mature. They contain hemoglobin, a protein that transports oxygen throughout the body. The typical lifespan of an RBC is 120 days; thus the bone marrow must continually produce new RBCs to replace those that age and disintegrate or are lost through bleeding. A number of conditions can affect the production of new RBCs and/or their lifespan, in addition to those conditions that may result in significant bleeding.

The CBC determines the number of RBCs and amount of hemoglobin present, the proportion of blood made up of RBCs (hematocrit), and whether the population of RBCs appears to be normal. RBCs normally are uniform with minimal variations in size and shape; however, significant variations can occur with conditions such as vitamin B12 and folate deficiencies, iron deficiency, and with a variety of other conditions. If the concentration of red blood cells and/or the amount of hemoglobin in the blood drops below normal, a person is said to have anemia and may have symptoms such as fatigue and weakness. Much less frequently, there may be too many RBCs in the blood (erythrocytosis or polycythemia). In extreme cases, this can interfere with the flow of blood through the small veins and arteries.

Platelets
Platelets, also called thrombocytes, are special cell fragments that play an important role in normal blood clotting. A person who does not have enough platelets may be at an increased risk of excessive bleeding and bruising. An excess of platelets can cause excessive clotting or, if the platelets are not functioning properly, excessive bleeding. The CBC measures the number and size of platelets present.

Accordion Title
Common Questions
  • How is it used?

    The complete blood count (CBC) is often used as a broad screening test to determine an individual's general health status. It can be used to:

    • Screen for a wide range of conditions and diseases
    • Help diagnose various conditions, such as anemia, infection, inflammation, bleeding disorder or leukemia, to name just a few
    • Monitor the condition and/or effectiveness of treatment after a diagnosis is established
    • Monitor treatment that is known to affect blood cells, such as chemotherapy or radiation therapy

    A CBC is a panel of tests that evaluates the three types of cells that circulate in the blood. A CBC includes the following:

    • Evaluation of white blood cells, the cells that are part of the body's defense system against infections and cancer and also play a role in allergies and inflammation:
      • White blood cell (WBC) count is a count of the total number of white blood cells in a person's sample of blood.
      • White blood cell differential may or may not be included as part of the panel of tests. It identifies and counts the number of the various types of white blood cells present. The five types include neutrophils, lymphocytes, monocytes, eosinophils, and basophils.
    • Evaluation of red blood cells, the cells that transport oxygen throughout the body:
      • Red blood cell (RBC) count is a count of the actual number of red blood cells in a person's sample of blood.
      • Hemoglobin measures the total amount of the oxygen-carrying protein in the blood, which generally reflects the number of red blood cells in the blood.
      • Hematocrit measures the percentage of a person's total blood volume that consists of red blood cells.
      • Red blood cell indices are calculations that provide information on the physical characteristics of the RBCs:
        • Mean corpuscular volume (MCV) is a measurement of the average size of a single red blood cell.
        • Mean corpuscular hemoglobin (MCH) is a calculation of the average amount of hemoglobin inside a single red blood cell.
        • Mean corpuscular hemoglobin concentration (MCHC) is a calculation of the average concentration of hemoglobin inside a single red blood cell.
        • Red cell distribution width (RDW) is a calculation of the variation in the size of RBCs.
      • The CBC may also include reticulocyte count, which is a measurement of the absolute count or percentage of young red blood cells in blood.
    • Evaluation of platelets, cell fragments that are vital for normal blood clotting:
      • The platelet count is the number of platelets in a person's sample of blood.
      • Mean platelet volume (MPV) may be reported with a CBC. It is a calculation of the average size of platelets.
      • Platelet distribution width (PDW) may also be reported with a CBC. It reflects how uniform platelets are in size.
  • When is it ordered?

    The CBC is a very common test. Many people have a CBC performed when they have a routine health examination. If a person is healthy and has results that are within normal limits, then that person may not require another CBC until their health status changes or until their healthcare provider feels that it is necessary.

    A CBC may be ordered when a person has any number of signs and symptoms that may be related to disorders that affect blood cells. When an individual has fatigue or weakness or has an infection, inflammation, bruising, or bleeding, a health practitioner may order a CBC to help diagnose the cause and/or determine its severity.

    When a person has been diagnosed with a disease known to affect blood cells, a CBC will often be ordered on a regular basis to monitor their condition. Likewise, if someone is receiving treatment for a blood-related disorder, then a CBC may be performed frequently to determine if the treatment is effective.

    Some therapies, such as chemotherapy, can affect bone marrow production of cells. Some medications can decrease WBC counts overall. A CBC may be ordered on a regular basis to monitor these drug treatments.

  • What does the test result mean?

    A health practitioner typically evaluates and interprets results from the components of the CBC together. Depending on the purpose of the test, a number of additional or follow-up tests may be ordered for further investigation.

    The following tables briefly and generally explain what the result for each component of the CBC may mean.

    For detailed information on each test component, click on the name of the component to go to the specific article.

    To see an example of a CBC lab report, see this sample report.

    Note: The reference ranges provided here represent a theoretical guideline that should not be used to interpret your test results. Some variation is likely between these numbers and the reference range reported by the lab that ran your test. Please consult your doctor. For more information on reference ranges, please read Reference Ranges and What They Mean.

    Reference ranges listed here are for adults older than 18 years old. They are not available for youths 0-18 years old due to wide variability. See the child's lab report for reference ranges.

    Conventional Units are typically used for reporting results in U.S. labs. SI Units are used to report lab results outside of the U.S.

    Components of the CBC

    WBC Evaluation 

    Test Reference Range2 Examples of causes of a low count Examples of causes of a high count

    White Blood Cell Count

    (WBC)

     

    Conventional Units1

    4,500-11,000 white blood cells per microliter (mcL)

    SI Units1

    4.5-11.0 x 109 per liter (L)

    Known as leukopenia Known as leukocytosis

    White Blood Cell Differential

    (Diff)

    (Not always performed; may be done as part of or in follow up to CBC)

       

    Absolute neutrophil count, % neutrophils

    (Neu, PMN, polys)

    Conventional Units

    Percent (mean): 56% 

    Absolute count (per microliter): 
    1800-7800

    SI Units

    Mean number fraction: 0.56 

    Absolute count X 109 per liter:
    1.8-7.8 

    Known as neutropenia
    • Severe, overwhelming infection (sepsis)
    • Autoimmune disorders
    • Dietary deficiencies
    • Reaction to drugs
    • Immunodeficiency
    • Myelodysplasia
    • Bone marrow damage (e.g., chemotherapy, radiation therapy)
    • Cancer that spreads to the bone marrow
    Known as neutrophilia
    • Acute bacterial infections
    • Inflammation
    • Trauma, heart attack, or burns
    • Stress, rigorous exercise
    • Certain leukemias (e.g., chronic myeloid leukemia)
    • Cushing syndrome

    Absolute lymphocyte count, % lymphocytes

    (Lymph)

    Conventional Units

    Percent (mean) 34%
    Absolute count (per microliter):
    1000-4800

    SI Units

    Mean number fraction: 0.34
    Absolute count X 109 per liter: 
    1.0-4.8

    Known as lymphocytopenia Known as lymphocytosis

    Absolute monocyte count, % monocytes
    (Mono)

    Conventional Units

    Percent (mean) 4%
    Absolute count (per microliter)
    0-800

    SI Units

    Mean number fraction 0.04
    Absolute count X 109 per liter 
    0-0.80

    Usually, one low count is not medically significant.

    Repeated low counts can indicate:

    • Chronic infections (e.g., tuberculosis, fungal infection)
    • Infection within the heart (bacterial endocarditis)
    • Collagen vascular diseases (e.g., lupus, scleroderma, rheumatoid arthritis, vasculitis)
    • Monocytic or myelomonocytic leukemia (acute or chronic)

    Absolute eosinophil count, % eosinophils

    (Eos)

    Conventional Units

    Percent (mean) 2.7%
    Absolute count (per microliter)
    0-450

    SI Units

    Mean number fraction 0.027
    Absolute count X 109 per liter
    0-0.45

    Numbers are normally low in the blood. One or an occasional low number is usually not medically significant

    Absolute basophil count, % basophils

    (Baso)

    Conventional Units

    Percent (mean) 0.3%
    Absolute count (per microliter)
    0-200

    SI Units

    Mean number fraction 0.030
    Absolute count X 109 per liter
    0-0.20

    As with eosinophils, numbers are normally low in the blood; usually not medically significant
    • Rare allergic reactions (hives, food allergy)
    • Inflammation (rheumatoid arthritis, ulcerative colitis)
    • Some leukemias
    • Uremia

     

    RBC Evaluation 

    TEST Reference Range2 Examples of causes of low result Examples of causes of high result

    Red Blood Cell Count
    (RBC)

    Conventional Units

    Men: 4.5-5.9 x 106/microliter

    Women: 4.5-5.1 x 106 microliter

    SI Units

    Men: 4.5-5.9 x 1012/L

    Women: 4.1-5.1 x 1012/L

    Known as anemia
    • Acute or chronic bleeding
    • RBC destruction (e.g., hemolytic anemia, etc.)
    • Nutritional deficiency (e.g., iron deficiency, vitamin B12 or folate deficiency)
    • Bone marrow disorders or damage
    • Chronic inflammatory disease
    • Chronic kidney disease
    Known as polycythemia
    • Dehydration
    • Lung (pulmonary) disease
    • Kidney or other tumor that produces excess erythropoietin
    • Smoking
    • Living at high altitude
    • Genetic causes (altered oxygen sensing, abnormality in hemoglobin oxygen release)
    • Polycythemia vera—a rare disease

    Hemoglobin

    (Hb)

    Conventional Units

    Men: 14-17.5 g/dL

    Women: 12.3-15.3 g/dL

    SI Units

    Men: 140-175 g/L

    Women: 123-153 g/L

    Usually mirrors RBC results, provides added information Usually mirrors RBC results

    Hematocrit

    (Hct)

    Conventional Units

    Men: 41.5-50.4%

    Women: 36.9-44.6%

    SI Units

    Men: 0.415-0.504 volume fraction

    Women: 0.369-0.446 volume fraction

    Usually mirrors RBC results Usually mirrors RBC results; most common cause is dehydration
    RBC indices      
    MCV

    Conventional Units

    80-96 micrometer3

    SI Units

    80-96 fL

    Indicates RBCs are smaller than normal (microcytic); caused by iron deficiency anemia or thalassemias, for example. Indicates RBCs are larger than normal (macrocytic), for example in anemia caused by vitamin B12 or folate deficiency, myelodysplasialiver diseasehypothyroidism
    MCH

    Conventional Units

    27.5-33.2 pg

    SI Units

    27.5-33.2 pg

    Mirrors MCV results; small red cells would have a lower value. Mirrors MCV results; macrocytic RBCs are large so tend to have a higher MCH.
    MCHC

    Conventional Units

    33.4-35.5 g/dL

    SI Units

    334-355 g/L

    May be low when MCV is low; decreased MCHC values (hypochromia) are seen in conditions such as iron deficiency anemia and thalassemia. Increased MCHC values (hyperchromia) are seen in conditions where the hemoglobin is more concentrated inside the red cells, such as autoimmune hemolytic anemia, in burn patients, and hereditary spherocytosis, a rare congenital disorder.
    RDW (Not always reported) RBC Distribution Width Low value indicates uniformity in size of RBCs. Indicates mixed population of small and large RBCs; young RBCs tend to be larger. For example, in iron deficiency anemia or pernicious anemia, there is high variation (anisocytosis) in RBC size (along with variation in shape – poikilocytosis), causing an increase in the RDW.
    Reticulocyte Count (Not always done)

    Conventional Units

    0.5-1.5% or
    25-75 x 103/microliter

    SI Units

    0.005-0.015 number fraction or 
    25-75 x 109/L

    In the setting of anemia, a low reticulocyte count indicates a condition is affecting the production of red blood cells, such as bone marrow disorder or damage, or a nutritional deficiency (iron, B12 or folate). In the setting of anemia, a high reticulocyte count generally indicates peripheral cause, such as bleeding or hemolysis, or response to treatment (e.g., iron supplementation for iron deficiency anemia).

    Platelet Evaluation 

    Test Reference Range2 Examples of causes of low result Examples of causes of high result

    Platelet Count

    (Plt)

    Conventional Units

    150-450 x 103/microliter

    SI Units

    150-450 x 109/L

    Known as thrombocytopenia:
    • Viral infection (mononucleosismeasles, hepatitis)
    • Rocky mountain spotted fever
    • Platelet autoantibody
    • Drugs (acetaminophen, quinidine, sulfa drugs)
    • Cirrhosis
    • Autoimmune disorders
    • Sepsis
    • Leukemia, lymphoma
    • Myelodysplasia
    • Chemo or radiation therapy
    Know as thrombocytosis:
    • Cancer (lung, gastrointestinal, breastovarian, lymphoma)
    • Rheumatoid arthritis, inflammatory bowel disease, lupus
    • Iron deficiency anemia
    • Hemolytic anemia
    • Myeloproliferative disorder (e.g., essential thrombocythemia)

    MPV

    (Not always reported)

    Mean Platelet Volume Indicates average size of platelets is small; older platelets are generally smaller than younger ones and a low MPV may mean that a condition is affecting the production of platelets by the bone marrow. Indicates a high number of larger, younger platelets in the blood; this may be due to the bone marrow producing and releasing platelets rapidly into circulation.

    PDW

    (Not always reported)

    Platelet Distribution Width Indicates uniformity in size of platelets Indicates increased variation in the size of the platelets, which may mean that a condition is present that is affecting platelets

    1 from Wintrobe's Clinical Hematology. 12th ed. Greer J, Foerster J, Rodgers G, Paraskevas F, Glader B, Arber D, Means R, eds. Philadelphia, PA: Lippincott Williams & Wilkins: 2009.

    2 from Henry's Clinical Diagnosis and Management by Laboratory Methods. 22nd ed. McPherson R, Pincus M, eds. Philadelphia, PA: Elsevier Saunders; 2011.

     

  • Is there anything else I should know?

    Many different conditions can result in increases or decreases in blood cell populations. Some of these conditions may require treatment, while others may resolve on their own.

    Recent blood transfusions affect the results of the CBC.

    Normal CBC values for babies and children are different from adults. The laboratory will supply the reference ranges for various age groups, and a health practitioner will take these into consideration when interpreting data.

  • My CBC report includes a result for immature platelet fraction (IPF). What is it?

    IPF is the relative number of immature platelets (also called reticulated platelets) in the blood. Platelets are produced in the bone marrow and are normally not released into the bloodstream until they have matured. When platelet numbers in the blood are low (thrombocytopenia), it stimulates the bone marrow to produce platelets faster. When the need is great and when production cannot keep up with "demand," then an increased number of immature platelets will be released into the bloodstream.

    This IPF test result would be one of the values reported when blood is evaluated using an automated hematology analyzer. The IPF may be used to help a healthcare provider determine the likely cause of a person's thrombocytopenia, that is, decrease in production by the bone marrow (IPF is low) versus increased loss of platelets in the blood (IPF is higher). Lab test results including platelet count and IPF can also help determine if a person needs a platelet transfusion and help monitor bone marrow recovery, such as after a bone marrow transplant. Other uses are being studied and the test's ultimate clinical utility has not yet been well determined.

  • My CBC report includes a result for reticulocyte hemoglobin. What is it?

    The hemoglobin inside of reticulocytes can be measured and reported as either a mean reticulocyte hemoglobin content (CHr) or a reticulocyte hemoglobin equivalent (Ret-He), depending upon the test method used. This test result would be one of the values reported when blood is evaluated using an automated hematology analyzer.

    Reticulocytes are "young" red blood cells that are released by the bone marrow before they become fully mature. The amount of hemoglobin inside of reticulocytes can help determine if there has been enough iron available, to be incorporated into hemoglobin production and then into red blood cell production in the bone marrow, within the past few days. This makes the test useful in identifying functional iron deficiency in certain clinical conditions and in assessing iron deficiency anemia in children.

  • My CBC report includes a result for immature granulocytes (IG). What are they?

    Some automated hematology analyzers report the total number of immature granulocytes (IG) present in a person's blood sample. Immature granulocytes are white blood cells that have not fully developed before being released from the bone marrow into the blood. They may include metamyelocytes, myelocytes, and promyelocytes. These cells are normally only present in the bone marrow because they are precursors of neutrophils, the predominant type of white cells in blood. The presence of immature granulocytes in the blood may occur in various diseases, such as infection or a blood cancer, and thus will often prompt further investigation, which may include additional laboratory testing.

  • Is there anything I can do to improve results of my CBC?

    People who have a keen interest in their own health care frequently want to know what they can do to change their WBCs, RBCs, and platelets. Unlike "good" and "bad" cholesterol, cell populations are not generally affected by lifestyle changes unless the individual has an underlying deficiency (such as vitamin B12 or folate deficiency or iron deficiency). There is no way that a person can directly raise the number of his WBCs or change the size or shape of his RBCs. Addressing any underlying diseases or conditions and following a healthy lifestyle will help optimize your body's cell production, and your body will take care of the rest.

  • If I have an abnormal result on my CBC, what other tests might my doctor order as follow up?

    It depends on the results that are abnormal and the suspected cause as well as your medical history and findings from your physical examination. Your healthcare provider may request that a blood smear examination be done. Other general tests to check your health and to look for possible causes may include a comprehensive metabolic panel (CMP). A few other general examples include:

    • Abnormal results for WBCs may be followed by a culture of the affected area (e.g., blood culture, urine culture, sputum culture), a strep test or tests for viruses such as mononucleosis or EBV. If inflammation is suspected, then a CRP or ESR test may be done.

    • Abnormal RBC results may prompt a reticulocyte count, iron studies, tests for vitamin B12 and folate, G6PD, or hemoglobinopathy evaluation to help make a diagnosis.

    • An abnormal platelet count may be followed by tests that further evaluate platelets, such as platelet function tests or HIT antibody. Additional tests may be done to check for bleeding disorders or excessive clotting disorders such as PT, PTT, von Willebrand factor or coagulation factors.

    When a serious condition such as leukemia, myelodysplasia or another bone marrow disorder is suspected, then a bone marrow biopsy and examination may be necessary. Numerous other tests specific for certain conditions may be needed to establish a diagnosis. Talk to your healthcare provider about the results of your CBC, whether additional tests are necessary, and why.

You may be able to find your test results on your laboratory's website or patient portal. However, you are currently at Lab Tests Online. You may have been directed here by your lab's website in order to provide you with background information about the test(s) you had performed. You will need to return to your lab's website or portal, or contact your healthcare practitioner in order to obtain your test results.

Lab Tests Online is an award-winning patient education website offering information on laboratory tests. The content on the site, which has been reviewed by laboratory scientists and other medical professionals, provides general explanations of what results might mean for each test listed on the site, such as what a high or low value might suggest to your healthcare practitioner about your health or medical condition.

The reference ranges for your tests can be found on your laboratory report. They are typically found to the right of your results.

If you do not have your lab report, consult your healthcare provider or the laboratory that performed the test(s) to obtain the reference range.

Laboratory test results are not meaningful by themselves. Their meaning comes from comparison to reference ranges. Reference ranges are the values expected for a healthy person. They are sometimes called "normal" values. By comparing your test results with reference values, you and your healthcare provider can see if any of your test results fall outside the range of expected values. Values that are outside expected ranges can provide clues to help identify possible conditions or diseases.

While accuracy of laboratory testing has significantly evolved over the past few decades, some lab-to-lab variability can occur due to differences in testing equipment, chemical reagents, and techniques. This is a reason why so few reference ranges are provided on this site. It is important to know that you must use the range supplied by the laboratory that performed your test to evaluate whether your results are "within normal limits."

For more information, please read the article Reference Ranges and What They Mean.

See "What does the test result mean?" below for CBC reference ranges.

View Sources

Sources Used in Current Review

Bain B J. The peripheral blood smear. In Goldman L, Schafer AI. (© 2012). Goldman's Cecil Medicine 24th Edition: Elsevir Saunders, Philadelphia, PA. Pp 1024-1031.

Pagana, Kathleen D., Pagana, Timothy J., and Pagana, Theresa N. (© 2015). Mosby's Diagnostic and Laboratory Test Reference 12th Edition: Mosby, Inc., Saint Louis, MO. Pp 497-501, 786-789, 991-995.

National Heart, Lung, and Blood Institute (2012 May 18 Updated). Anemia. Available online at http://www.nhlbi.nih.gov/health/health-topics/topics/anemia through http://www.nhlbi.nih.gov. Accessed 4/8/2015.

National Heart, Lung, and Blood Institute (2013 December 30 Updated). Lymphocytopenia Available online at http://www.nhlbi.nih.gov/health/health-topics/topics/lym through http://www.nhlbi.nih.gov. Accessed 4/8/2015.

National Heart, Lung, and Blood Institute (2012 31 July Updated). What is thrombocytopenia? Available online at http://www.nhlbi.nih.gov/health/health-topics/topics/thcp through http://www.nhlbi.nih.gov. Accessed 3/20/2015.

National Heart, Lung, and Blood Institute (2012 31 July Updated). What are thrombocythemia and thrombocytosis? Available online at http://www.nhlbi.nih.gov/health/health-topics/topics/thrm/ through http://www.nhlbi.nih.gov. Accessed 3/20/2015.

Inoue S. (7 February 2014 Updated) Leukocytosis. Medscape Reference Article. Available online at http://emedicine.medscape.com/article/956278-overview through http://emedicine.medscape.com. Accessed 4/5/2015.

(January 14, 2015) Curry C. White Blood Cell Differential. Medscape Reference. Available online at http://emedicine.medscape.com/article/2085133-overview#a2 through http://emedicine.medscape.com. Accessed July 10, 2015.

Yuko, S. et. al. (2013 October). Examination of the Percentage of Immature Platelet Fraction in Term and Preterm Infants at Birth. J Clin Neonatol. 2013 Oct-Dec; 2(4): 173–178. [On-line information]. Available online at http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3883212/ through http://www.ncbi.nlm.nih.gov. Accessed 07/18/15.

Hoffman, J.J. (2014). Reticulated platelets: analytical aspects and clinical utility. Clin Chem Lab Med. 2014; 52(8):1107-17. Available online at http://www.degruyter.com/view/j/cclm.2014.52.issue-8/cclm-2014-0165/cclm-2014-0165.xml through http://www.degruyter.com. Accessed 07/25/15.

Szigeti, R. and Curry, C. (2014 September 5, Updated). Reticulocyte Count and Reticulocyte Hemoglobin Content. Medscape Drugs & Diseases [On-line information]. Available online at http://emedicine.medscape.com/article/2086146-overview through http://emedicine.medscape.com. Accessed 07/18/15.

Peerschke, E. (2014). Using the Hemoglobin Content of Reticulocytes (RET-He) to Evaluate Anemia in Patients With Cancer. Medscape News & Perspective. Am J Clin Pathol. 2014;142(4):506-512. [On-line information]. Available online at http://www.medscape.com/viewarticle/833778 through http://www.medscape.com. Accessed 07/18/15.

Keohane, E, Smith, L. and Walenga, J. (© 2016). Rodak's Hematology Clinical Principles and Applications 5th Edition: Elsevier Saunders, Saint Louis, MO. Pp 145, 173.

Sources Used in Previous Reviews

Clinical Hematology: Principles, Procedures, Correlations. Second edition. E. Anne Stiene-Martin, Cheryl A. Lotspeich-Steininger, John A. Koepke. Lippincott Co. 1998.

Clinical Hematology and Fundamentals of Hemostasis. Third edition. Denise M. Harmening.F. A. Davis Co., 1915 Arch Street Philadelphia, PA 19103. 1997.

Thomas, Clayton L., Editor (1997). Taber's Cyclopedic Medical Dictionary. F.A. Davis Company, Philadelphia, PA [18th Edition].

Pagana, Kathleen D. & Pagana, Timothy J. (2001). Mosby's Diagnostic and Laboratory Test Reference 5th Edition: Mosby, Inc., Saint Louis, MO.

Brose, M., Updated (2004 August 03, Updated). CBC. MedlinePlus Health Information, Medical Encyclopedia [On-line information]. Available online at http://www.nlm.nih.gov/medlineplus/ency/article/003642.htm.

Brose, M, Updated (2003 May 08, Updated). Blood differential. MedlinePlus Health Information, Medical Encyclopedia [On-line information]. Available online at http://www.nlm.nih.gov/medlineplus/ency/article/003657.htm.

Pagana, Kathleen D. & Pagana, Timothy J. (© 2007). Mosby's Diagnostic and Laboratory Test Reference 8th Edition: Mosby, Inc., Saint Louis, MO. Pp 290.

Harmening D. Clinical Hematology and Fundamentals of Hemostasis, Fifth Edition, F.A. Davis Company, Philadelphia, 2009, Chap 3, Pp 305-328, 578-589.

Henry's Clinical Diagnosis and Management by Laboratory Methods. 21st ed. McPherson R, Pincus M, eds. Philadelphia, PA: Saunders Elsevier: 2007, Chap. 31, Pp 477-478, 545-560, 730, 754-757.

Wintrobe's Clinical Hematology. 12th ed. Greer J, Foerster J, Rodgers G, Paraskevas F, Glader B, Arber D, Means R, eds. Philadelphia, PA: Lippincott Williams & Wilkins: 2009, Pp 170-402, 1512-1516, 1522-1524, 1528-1533.

Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL eds, (2005). Harrison's Principles of Internal Medicine, 16th Edition, McGraw Hill, Pp 329-336, 340-341, 673-675.

Pagana K, Pagana T. Mosby's Manual of Diagnostic and Laboratory Tests. 3rd Edition, St. Louis: Mosby Elsevier; 2006, Pp 409-412, 447-448.

(Updated May 10, 2010) Inoue S, et al. Leukocytosis, Medscape Reference article. Available online at http://emedicine.medscape.com/article/956278-overview through http://emedicine.medscape.com. Accessed May 2012.

(February 1, 2011) National Heart Lung Blood Institute. What is lymphocytopenia? Available online at http://www.nhlbi.nih.gov/health/health-topics/topics/lym/ through http://www.nhlbi.nih.gov. Accessed May 2012.

(January 8 2010) Kempert P. White Blood Cell Function, Overview of the Immune System. Medscape Reference article. Available online at http://emedicine.medscape.com/article/960027-overview through http://emedicine.medscape.com. Accessed May 2012.

(January 6, 2010) Naushad H. Leukocyte Count (WBC). Medscape Reference article. Available online at http://emedicine.medscape.com/article/2054452-overview#aw2aab6b2 through http://emedicine.medscape.com. Accessed May 2012.

(Updated December 5, 2011) Nader N. Neutrophilia. Medscape Reference article. Available online at http://emedicine.medscape.com/article/208576-overview through http://emedicine.medscape.com. Accessed May 2012.

(May 24, 2011) Godwin J. Neutropenia. Medscape Reference article. Available online at http://emedicine.medscape.com/article/204821-overview through http://emedicine.medscape.com. Accessed May 2012.

(August 25, 2011) Liss M. Eosinophilia. Medscape Reference article. Available online at http://emedicine.medscape.com/article/199879-overview through http://emedicine.medscape.com. Accessed May 2012.

(March 1, 2011) National Heart, Lung and Blood Institute. What is Polycythemia vera? Available online at http://www.nhlbi.nih.gov/health/health-topics/topics/poly/ through http://www.nhlbi.nih.gov. Accessed May 2012.

(May 18 2012) National Heart, Lung and Blood Institute. Anemia. Available online at http://www.nhlbi.nih.gov/health/health-topics/topics/anemia/ through http://www.nhlbi.nih.gov. Accessed May 2012.

(November 4, 2011) Maakaron J. Anemia. Medscape Reference article. Available online at http://emedicine.medscape.com/article/198475-overview through http://emedicine.medscape.com. Accessed May 2012.

(April 19, 2012) Dugdale D. RBC Count. MedlinePlus Medical Encyclopedia. Available online at http://www.nlm.nih.gov/medlineplus/ency/article/003644.htm. Accessed May 2012.

Riley R, et.al. Automated Hematologic Evaluation. Medical College of Virginia, Virginia Commonwealth University. Available online at http://www.pathology.vcu.edu/education/PathLab/pages/hematopath/pbs.html#Anchor-Automated-47857 through http://www.pathology.vcu.edu. Accessed May 2012.

(August 1, 2010) National Heart, Lung and Blood Institute. What are thrombocythemia and thrombocytosis? Available online at http://www.nhlbi.nih.gov/health/health-topics/topics/thrm/ through http://www.nhlbi.nih.gov. Accessed May 2012.

(Aug 1, 2010) National Heart, Lung and Blood Institute. What is thrombocytopenia? Available online at http://www.nhlbi.nih.gov/health/health-topics/topics/thcp/ through http://www.nhlbi.nih.gov. Accessed May 2012.

(July 16, 2010) Mayo Clinic. Diseases and Conditions, Thrombocytosis. Available online at http://www.mayoclinic.com/health/thrombocytosis/DS01088 through http://www.mayoclinic.com. Accessed May 2012.

Ask a Laboratory Scientist

 

Your questions will be answered by a laboratory scientist as part of a voluntary service provided by one of our partners, the American Society for Clinical Laboratory Science (ASCLS). Click on the Contact a Scientist button below to be re-directed to the ASCLS site to complete a request form. If your question relates to this web site and not to a specific lab test, please submit it via our Contact Us page instead. Thank you.

Contact a Scientist